About Massachusetts General Hospital Schizophrenia Program
Clinical Trials at Massachusetts General Hospital Schizophrenia Program
During the past decade, Massachusetts General Hospital Schizophrenia Program conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Massachusetts General Hospital Schizophrenia Program"
#1 collaborator was "National Alliance for Research on Schizophrenia and Depression" with 1 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 1 trials as a collaborator and "Stanley Medical Research Institute" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Massachusetts General Hospital Schizophrenia Program
According to Clinical.Site data, the most researched conditions in "Massachusetts General Hospital Schizophrenia Program" are
"Schizophrenia" (2 trials) and "Insulin Resistance" (1 trials). Many other conditions were trialed in "Massachusetts General Hospital Schizophrenia Program" in a lesser frequency.
Clinical Trials Intervention Types at Massachusetts General Hospital Schizophrenia Program
Most popular intervention types in "Massachusetts General Hospital Schizophrenia Program" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Aripiprazole" (1 trials), "Placebo" (1 trials), "placebo" (1 trials) and "rosiglitazone" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Massachusetts General Hospital Schizophrenia Program
The vast majority of trials in "Massachusetts General Hospital Schizophrenia Program" are
2 trials for "All" genders.
Clinical Trials Status at Massachusetts General Hospital Schizophrenia Program
Currently, there are NaN active trials in "Massachusetts General Hospital Schizophrenia Program".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Massachusetts General Hospital Schizophrenia Program,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Massachusetts General Hospital Schizophrenia Program, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".